Novo Nordisk
Hugo Starrsjo is an experienced professional currently serving as Associate Director and Project Data Lead at Novo Nordisk, focusing on the integration of Data Science and drug-development strategy in cardiovascular projects. As COO and Co-Founder of LYS Technologies, Hugo leads initiatives aimed at enhancing health through innovative lighting solutions. Previous experience includes roles as a Strategy Consultant and Strategy Consulting Analyst at Candesic, where responsibilities involved strategy and commercial due diligence for prominent Private Equity funds and public sector entities. Hugo holds a Master’s Degree from HEC Paris and a MEng (Hons) in Biomedical Engineering from Imperial College London, along with a French Baccalaureate from Lycée Français Charles de Gaulle de Londres.
Novo Nordisk
369 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.